» Articles » PMID: 35034049

Risk of Human Immunodeficiency Virus Acquisition Among High-Risk Heterosexuals With Nonviral Sexually Transmitted Infections: A Systematic Review and Meta-Analysis

Overview
Journal Sex Transm Dis
Date 2022 Jan 16
PMID 35034049
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonviral sexually transmitted infections (STIs) increase risk of sexually acquired human immunodeficiency virus (HIV) infection. Updated risk estimates carefully scrutinizing temporality bias of studies are needed.

Methods: We conducted a systematic review (PROSPERO CRD42018084299) of peer-reviewed studies evaluating variation in risk of HIV infection among high-risk heterosexuals diagnosed with any of: Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, Treponema pallidum, and/or Trichomonas vaginalis. We searched PubMed, Web of Science, and Embase databases through December 2017 and included studies where STIs and HIV were assessed using laboratory tests or medical examinations and where STI was diagnosed before HIV. After dual screening, data extraction, and risk of bias assessment, we meta-analytically pooled risk ratios (RRs).

Results: We found 32 eligible studies reporting k = 97 effect size estimates of HIV acquisition risk due to infection with one of the abovementioned STIs. Most data were based on women engaged in sex work or other high-risk occupations in developing countries. Many studies did not measure or adjust for known confounders, including drug injection and condom use, and most were at medium or high risk of bias because of the potential for undetected HIV infection to have occurred before STI infection. Human immunodeficiency virus acquisition risk increased among women infected with any pathogen; the effect was greatest for women infected with Mycoplasma genitalium (RR, 3.10; 95% confidence interval [CI], 1.63-5.92; k = 2) and gonorrhea (RR, 2.81; 95% CI, 2.25-3.50; k = 16) but also statistically significant for women infected with syphilis (RR, 1.67; 95% CI, 1.23-2.27; k = 17), trichomonas (RR, 1.54; 95% CI, 1.31-1.82; k = 17), and chlamydia (RR, 1.49; 95% CI, 1.08-2.04; k = 14). For men, data were space except for syphilis (RR, 1.77; 95% CI, 1.22-2.58; k = 5).

Conclusion: Nonviral STI increases risk of heterosexual HIV acquisition, although uncertainty remains because of risk of bias in primary studies.

Citing Articles

Efficacy of Doxycycline-Sitafloxacin Sequential Therapy for Urogenital Mycoplasma genitalium Infection in Nanjing, China.

Yuan M, Le W, Zhao Y, Gan L, Li S, Su X Sex Transm Dis. 2025; 52(4):259-265.

PMID: 40053328 PMC: 11878589. DOI: 10.1097/OLQ.0000000000002105.


Antimicrobial Resistance in Curable Sexually Transmitted Infections.

Giacani L, Bradshaw C, Muzny C, Graves K, Pasricha S, Jordan S Curr HIV/AIDS Rep. 2025; 22(1):14.

PMID: 39856345 DOI: 10.1007/s11904-025-00722-7.


The impact of sex on HIV immunopathogenesis and therapeutic interventions.

Mihealsick E, Word A, Scully E J Clin Invest. 2024; 134(18).

PMID: 39286972 PMC: 11405047. DOI: 10.1172/JCI180075.


HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania.

Sultana C, Falanga C, Chicin G, Ion L, Grancea C, Chiriac D Viruses. 2024; 16(8).

PMID: 39205253 PMC: 11360329. DOI: 10.3390/v16081279.


Role of microRNAs in immune regulation and pathogenesis of Chlamydia trachomatis and Chlamydia muridarum infections: a rapid review.

Meewes C, Gupta K, Geisler W Microbes Infect. 2024; 26(8):105397.

PMID: 39025257 PMC: 11609027. DOI: 10.1016/j.micinf.2024.105397.